Search This Blog

Friday, February 12, 2021

Citigroup Downgrades Alnylam Pharmaceuticals to Neutral

 Ups  target to $175

https://www.benzinga.com/news/21/02/19639618/citigroup-downgrades-alnylam-pharmaceuticals-to-neutral-raises-price-target-to-175

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.